NM_172107.4(KCNQ2):c.1603G>A (p.Gly535Ser) AND Autism spectrum disorder
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Nov 19, 2020
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV003128015.1
Allele description [Variation Report for NM_172107.4(KCNQ2):c.1603G>A (p.Gly535Ser)]
NM_172107.4(KCNQ2):c.1603G>A (p.Gly535Ser)
Condition(s)
- Name:
- Autism spectrum disorder
- Synonyms:
- Autism spectrum disorders
- Identifiers:
- MONDO: MONDO:0005258; MeSH: D000067877; MedGen: C1510586
-
Mus musculus protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF),...
Mus musculus protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 (Ppfia2), transcript variant 11, mRNAgi|1327850314|ref|NM_001359680.1|Nucleotide
-
PREDICTED: Homo sapiens MAPK activated protein kinase 3 (MAPKAPK3), transcript v...
PREDICTED: Homo sapiens MAPK activated protein kinase 3 (MAPKAPK3), transcript variant X6, mRNAgi|2462592456|ref|XM_054347798.1|Nucleotide
-
Mus musculus hydroxysteroid (17-beta) dehydrogenase 6 (Hsd17b6), transcript vari...
Mus musculus hydroxysteroid (17-beta) dehydrogenase 6 (Hsd17b6), transcript variant 8, mRNAgi|2707682253|ref|NM_001428925.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: May 6, 2023